Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser

J Hematother Stem Cell Res. 2001 Dec;10(6):721-4. doi: 10.1089/152581601317210818.
No abstract available

Publication types

  • Historical Article
  • Interview

MeSH terms

  • Antineoplastic Agents / history
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents / toxicity
  • Benzamides
  • Enzyme Inhibitors / therapeutic use
  • History, 20th Century
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Piperazines / history
  • Piperazines / therapeutic use*
  • Piperazines / toxicity
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / history
  • Pyrimidines / therapeutic use*
  • Pyrimidines / toxicity

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases